Cargando…
Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection
OBJECTIVES: The diffusion of the SARS-CoV-2 Delta (B.1.617.2) variant and the waning of immune response after primary Covid-19 vaccination favoured the breakthrough SARS-CoV-2 infections in vaccinated subjects. To assess the impact of vaccination, we determined the severity of infection in hospitali...
Autores principales: | Epaulard, Olivier, Abgrall, Sophie, Lefebvre, Maeva, Faucher, Jean-François, Michon, Jocelyn, Frentiu, Emilia, Blanchi, Sophie, Janssen, Cécile, Charbonnier, Gabrielle, Fresse, Audrey, Laurent, Simon, Sandjakian, Lena, Casez, Pierre, Mahamat, Aba, Beraud, Guillaume |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242694/ https://www.ncbi.nlm.nih.gov/pubmed/35779764 http://dx.doi.org/10.1016/j.cmi.2022.06.019 |
Ejemplares similares
-
Caractéristiques des patients hospitalisés avec un variant delta du SARS-CoV-2 (B.1.617.2) selon leur statut vaccinal
por: Epaulard, O., et al.
Publicado: (2022) -
Genome Sequences of the Delta Variant (B.1.617.2) and the Kappa Variant (B.1.617.1) Detected in Morocco
por: Melloul, Marouane, et al.
Publicado: (2021) -
Impact of vaccination on the presence and severity of symptoms in hospitalized patients with an infection of the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1)
por: Beraud, Guillaume, et al.
Publicado: (2023) -
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion
por: Ren, Wenlin, et al.
Publicado: (2022) -
A Bioinformatics Approach for the Prediction of Immunogenic Properties and Structure of the SARS-COV-2 B.1.617.1 Variant Spike Protein
por: Srivastava, Vijay Kumar, et al.
Publicado: (2021)